Scorecard
| Current Price | Fair | |
| Yield (%) – Higher is better Current Yield: 4.35% Industry Average: 3.17% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 3.33% Industry Average: 6.41% | ||
| Returns (%) – Higher is better Returns: 15.32% Industry Average: 14.07% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 40.06% Industry Average: 51.51% | ||
BRISTOL-MYERS SQUIBB COMPANY
(XNYS:BMY)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 57.89 | $ -0.19 |
Dividend
Annual Dividend | Annual Yield |
$ 2.52 | 4.35 % |
Dividend Streak | 5 Year Average |
17 year(s) | 3.93 % |
Fair Price
Current Stock price is considered: Fair
| Current Price ● $ 57.89 |
| Less Than $51.99 | $51.99 – $82.13 | More Than $82.13 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
3.33 % | 4.72 % | 6.65 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 1.96 | $ 2.16 | $ 2.28 | $ 2.40 | $ 2.48 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 7.69 15.32 % | $ -4.53 | -1.50 % |